Small molecule tau program(Aquinnah Pharmaceuticals)

N/A

Report date: 2024/03/21 17:21:33

Base Information

Drug NameSmall molecule tau program(Aquinnah Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAquinnah Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAquinnah Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A